Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.
about
DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth controlJun blockade of erythropoiesis: role for repression of GATA-1 by HERP2.Protein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infectionA liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approachesGlobal gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancerMolecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma.c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesisMitogenic regulation of p27(Kip1) gene is mediated by AP-1 transcription factors.Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran.Transactivation of proto-oncogene c-Myc by hepatitis B virus transactivator MHBs(t167.)c-Fos regulates hepatitis C virus propagation.Targeting c-Myc as a novel approach for hepatocellular carcinoma.MAPK signaling triggers transcriptional induction of cFOS during amino acid limitation of HepG2 cells.Molecular mechanisms underlying hepatocellular carcinomaMolecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.Gender Differences in Response to Prolonged Every-Other-Day Feeding on the Proliferation and Apoptosis of Hepatocytes in Micec-Jun N-terminal kinase is required for vitamin E succinate-induced apoptosis in human gastric cancer cellsThe effects of vitamin E succinate on the expression of c-jun gene and protein in human gastric cancer SGC-7901 cells.Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissuesCorrelation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone.Pathophysiological Significance of Hepatic ApoptosisGlucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4.Evaluate the Antigenotoxicity and Anticancer Role of β-Sitosterol by Determining Oxidative DNA Damage and the Expression of Phosphorylated Mitogen-activated Protein Kinases', C-fos, C-jun, and Endothelial Growth Factor Receptor.Dietary restriction protects against diethylnitrosamine-induced hepatocellular tumorigenesis by restoring the disturbed gene expression profile.The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.The -148 to -124 region of c-jun interacts with a positive regulatory factor in rat liver and enhances transcription.β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells.Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival.MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma.p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor.Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.Myosin phosphatase and RhoA-activated kinase modulate arginine methylation by the regulation of protein arginine methyltransferase 5 in hepatocellular carcinoma cells.Silica nanoparticles induce endoplasmic reticulum stress response and activate mitogen activated kinase (MAPK) signalling.Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency.Activation of transcription factors NF-kappaB and AP-1 and their relations with apoptosis associated-proteins in hepatocellular carcinoma.
P2860
Q24296626-7C38ED94-C55C-4B0C-9128-391226E7679FQ24562854-41D32E36-7B7E-451C-8FBF-043F73142F65Q28385007-E901DFED-7041-4771-A625-8E8DAD497976Q28392033-B1ECCB38-8124-494C-9DDB-1C401A7D46A3Q28829385-134C2EB5-E848-46F1-ACF3-4D8E7A537255Q30165307-4091DF2B-51E9-44C6-9A8C-A65525BECC9EQ33384492-3ADCEBCE-8CDE-4D34-9E27-8F91215472FCQ33654365-2FDA6963-6FE8-48FE-8724-AA5AD25DE2B4Q33717520-0A4C8C8F-F3A5-4A49-8F2A-4EDD18607DEAQ33787939-348E875E-5661-4065-9F09-67772B517222Q33844283-FE1F9106-C722-4F57-BF60-1552B6A91C99Q34020208-BA7A83A8-62CB-48C0-9BD3-F8B06DEACBDEQ34391522-2772C92A-9114-452C-96F7-7A915C95E3F0Q35044566-5E2E1175-B240-4E9C-BB7C-E24E3CB12085Q35260040-CB8361E9-2221-4D67-B7E4-CB741A115BD1Q35541482-7BE60A92-B41F-4591-8FC2-271942D7860BQ35809301-4D53FA33-72C3-41BA-9986-78042E1B2732Q35967415-9A0C8202-2B84-4362-9631-1CBC23D24497Q36308272-3F28DC1C-D497-42EF-8036-74D880B2EEA1Q36308954-CE84E7F4-CB01-408F-A179-0A7FE597ECC6Q36308973-6AA02F16-C192-4B8E-86DE-B2EF64254362Q36694963-F9ABC8CA-352B-4CF1-85B4-5EA798A30551Q36823677-4B6C9BDC-330E-43CF-81F6-2DA8E574F42CQ36961965-9F81A413-95F6-40B9-8622-B6694245C6F6Q36980627-9459C561-C01D-4C73-A178-B2E27C56F76AQ37640847-3EB5F2C1-15EC-48F8-A960-040819EA1266Q37682244-9225CC87-5832-4102-A7C6-375C0CB18522Q38178032-62539F4A-623F-4AA4-8278-D47840197B24Q38327752-E22A0CDB-1BD3-4637-900B-02DF3F243E1FQ38357290-1B13D9E1-D043-467A-BEC4-A5FCE66A2129Q38993024-24205927-3A41-4932-8043-BD607E76E016Q39102564-9550E0A6-7F7C-4FE9-9AFB-A98DA390A872Q39289102-8CB84C47-B2E3-41C1-9326-278F0F2A9065Q39897190-1FC9EA78-9823-4245-B894-D5AED2DF55D1Q40647690-F0846398-DD4F-48DE-8AF3-BBAC21C63775Q40740556-3BEE98B9-52FE-4259-BA6F-5791906CB5A7Q41195266-D3EE82BB-3187-44FB-A953-D92F123CD7F7Q41679204-64127210-C7E3-487F-AF57-D35D4DE3EB3FQ41863956-338FE562-910B-4F1F-A7D5-310BAE82F55AQ42034214-AF09EF68-24C1-4EBB-8206-6D7ECB7718A4
P2860
Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.
@en
type
label
Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.
@en
prefLabel
Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20010101)91:1<106::AID-CNCR14>3.0.CO;2-2
P407
P577
2001-01-01T00:00:00Z